FilingReader Intelligence

Zydus Lifesciences extends deadline for Sterling Biotech acquisition

March 28, 2025 at 07:05 PM UTCBy FilingReader AI

Zydus Lifesciences Limited (BSE: 532321) announced an extension to the completion date of its acquisition of the API business ("Target Business") of Sterling Biotech Limited (“SBL"). The new deadline is September 30, 2025. This extension follows an initial agreement to complete the transaction by December 31, 2024, and a subsequent extension to March 31, 2025. According to the company's announcement on March 28, 2025, SBL is still working to fulfill certain conditions precedent outlined in the Business Transfer Agreement (“BTA”). The company stated that the extension was mutually agreed upon. Zydus Lifesciences had previously informed investors about the acquisition plans, as per regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in earlier communications on September 17, 2024, and December 27, 2024.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

BSE:ZYDUSLIFEBombay Stock Exchange

News Alerts

Get instant email alerts when Zydus Lifesciences publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →